ETFMG Alternative Harvest ETF

Most Recent

  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Tobacco Use in Canada
    Company & Industry Overviews

    Why Product Landscape Design Matters for Cannabis Stocks

    The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.

    By Adam Jones
  • uploads///EBITDA and EBITDA Margin
    Basic Materials

    SMG’s Margin Expectations Could Be Concerning

    The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.

    By Adam Jones
  • uploads///Canopy Growths EPS
    Company & Industry Overviews

    Analysts’ Estimates for Canopy Growth’s Earnings

    Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.

    By Adam Jones
  • uploads///Chart
    Company & Industry Overviews

    MedMen’s Territory Expansion: The Recent Agreements

    MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.

    By Mike Benson
  • uploads///Tilray Kilograms Sold and Averaege Price
    Earnings Report

    Tilray’s Q2 2018 Results and Its Strategic Focus

    Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

    By Adam Jones
  • uploads///International strategy
    Company & Industry Overviews

    Law Firms Investigate Aphria for Potential Violations

    Due to Aphria’s (APHA) (APHQF) broad sell-off, several investors lost their investments. The investments might not be recovered.

    By Adam Jones
  • uploads///Int
    Company & Industry Overviews

    Will Canopy Growth Add Value to Constellation Brands?

    Constellation Brands said that Canopy Growth is a platform that can cater to medical and recreational customers.

    By Adam Jones
  • uploads///Uhhled
    Earnings Report

    Cronos Group Invests in the Future

    Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

    By Adam Jones
  • uploads///stock trading monitor desk
    Company & Industry Overviews

    Innovative Industrial Properties Declared Q1 Dividend

    On March 12, Innovative Industrial Properties’ board declared its first-quarter dividend. The company declared a dividend of $0.45 per share.

    By Peter Neil
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///Forward EV to Sales
    Miscellaneous

    Does Cronos Group Look Expensive Compared to Its Peers?

    Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    APHA, CTST, KSHB, and HEXO Gain to Break Their Losing Streaks

    Cannabis stocks have recently experienced weakness amid concerns surrounding a global slowdown and companies missing their earnings expectations.

    By Adam Jones
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///seedling _
    Company & Industry Overviews

    TLRY, CGC, CRON, and CTST Continue to Slide on April 11

    The first half of April 11 proved to be yet another dampener for cannabis investors’ expectations.

    By Adam Jones
  • uploads///Tilray Analysts NTM Recommendations and Targets
    Miscellaneous

    Tilray’s November Price Target and Recommendation Update

    Tilray (TLRY), which reported its earnings on November 13, missed both top-line and bottom-line consensus estimates.

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    SLNG, IIPR, and CTST Gain amid Sector Weakness

    The broader cannabis sector has traded largely in the negative so far on April 8 as investors have continued to be bearish.

    By Adam Jones
  • uploads///ebitda
    Real Estate

    Comparing the Valuation Multiples of Cannabis Stocks

    In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

    By Adam Jones
  • uploads///ITHUF_
    Company & Industry Overviews

    iAnthus to Open Three Dispensaries in Florida by End of 2018

    Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///
    Company & Industry Overviews

    APHA, CTST, and CRON Continue to Weaken on May 1

    The cannabis sector has been trading broadly flat ahead of the first-quarter earnings season.

    By Adam Jones
  • uploads///Canna
    Company & Industry Overviews

    Kamala Harris: Presidential Candidate for Legalizing Marijuana

    Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    Cannabis Roundup: ACB, HEXO, and CTST Lead the Pack

    On March 13, during the first half of the day, the overall cannabis sector traded higher.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Cannabis Stocks Continue to Struggle on the Last Day of April

    The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Will Santa Claus Rally Boost Cannabis Stocks?

    On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.

    By Margaret Patrick
  • uploads///Week_
    Miscellaneous

    Planet 13 and Wayland Group Posted Strong Performance Last Week

    Between March 29 and April 5, HMMJ and MJ rose 0.9% and 0.4%, respectively.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • uploads///green _
    Company & Industry Overviews

    Aphria: Last Week Was Eventful

    On December 27, Aphria came in play after Green Growth Brands announced its bid to take over the company for 11 Canadian dollars per share.

    By Adam Jones
  • uploads///canopy growth buy q
    Cannabis

    Why Canopy Growth Is a ‘Buy’ before Its Earnings

    Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///BL
    Cannabis

    Bruce Linton Joins Vireo Health as Executive Chairman

    Medical cannabis company Vireo Health International announced that it appointed Bruce Linton as its Executive Chairman. Linton co-founded Canopy Growth.

    By Rajiv Nanjapla
  • uploads///marijuana _
    Miscellaneous

    What Analysts Recommend for Cannabis Stocks in March

    Most of the major cannabis stocks are in the red on a year-to-date basis.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Curaleaf Opens Medical Marijuana Dispensary in Tallahassee

    On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.

    By Mike Benson
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///part
    Earnings Report

    How Analysts View Cresco Labs before Its Q1 Release

    Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.

    By Mohit Oberoi, CFA
  • uploads///CGC
    Cannabis

    CGC: How the Future Looks Under Its New CEO

    On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

    By Margaret Patrick
  • uploads///Green Organic Dutchman  Minute Chart
    Company & Industry Overviews

    TGOD: New IPO in the Cannabis Space Last Week

    The cannabis industry has seen a surge in producers seeking to gain a piece of the Canadian recreational cannabis market (MJ).

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Aurora Cannabis Comments on Coca-Cola Development

    Today, Aurora Cannabis (ACB) noted that while it doesn’t have a confirmed deal with Coca-Cola, it doesn’t reject the Coca-Cola development.

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    Tilray and Green Thumb Gain amid Broader Market Weakness

    Not all of the cannabis companies experienced a loss on April 2. Tilray (TLRY) rose ~1.6% around the middle of the day.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///herb _
    Company & Industry Overviews

    What to Expect from Cannabis Player Curaleaf’s Q3 Earnings

    A look at Curaleaf Curaleaf Holdings (LDVTF) is one of the leading cannabis operators in the United States. Curaleaf Holdings has announced that it will release its third-quarter earnings results on November 26. We’ll discuss analysts’ estimates for its EPS and revenue in this article. The chart above compares Curaleaf Holdings’ revenues since the third […]

    By Mike Benson
  • uploads///hemp leaf _
    Company & Industry Overviews

    Ups and Downs in the Cannabis Space Last Week

    The cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively.

    By Mohit Oberoi, CFA
  • uploads///Part  IIPR
    Company & Industry Overviews

    IIPR Stock Moves Higher after New Debt Is Raised

    Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.

    By Peter Neil
  • uploads///ACB_
    Cannabis

    Aurora Cannabis Releases Update on Cannabis 2.0

    Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Cannabis Stocks: What Happens in a Recession?

    As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    What’s the Market Potential for CBD?

    The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

    By Margaret Patrick
  • uploads///stinging nettle _
    Company & Industry Overviews

    Cannabis Updates: New Listings, Price Action, and Ratings

    The cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.

    By Mohit Oberoi, CFA
  • uploads///mexico
    Cannabis

    Will Mexico Legalize Cannabis by the End of the Month?

    With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

    By Rajiv Nanjapla
  • uploads///marijuana _
    Company & Industry Overviews

    One Chart That Shows What Makes Cannabis Attractive to Altria

    As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

    By Adam Jones
  • uploads///Supreme Cannabis Analysts NTM Recommendation and Target
    Miscellaneous

    Supreme Cannabis’ Target Price Changed in December

    Supreme Cannabis has been one of the worst performers in the cannabis sector year-to-date with a return of -49% as of December 19.

    By Adam Jones
  • Company & Industry Overviews

    Cannabis Stocks Roundup: Today’s Gains and Losses

    In the previous part of this series, we saw that most cannabis stocks (MJ) were trending lower today, but there were some gains as well.

    By Adam Jones
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///vaping
    Cannabis

    Vaping and Cannabis Stocks: Piper Jaffray Weighs In

    On October 8, Piper Jaffray senior analyst Michael Lavery voiced his opinions about the impact of vaping on cannabis stocks in an interview.

    By Margaret Patrick
  • uploads///cresco labs
    Cannabis

    Why Origin House’s Acquisition Is Vital for Cresco Labs

    On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

    By Rajiv Nanjapla
  • uploads///cannabis _
    Company & Industry Overviews

    OrganiGram Was the Biggest Cannabis Gainer Last Week

    Cannabis sector Overall, the cannabis sector broadly ended in the positive territory for the week ending March 1—compared to the closing on February 22. The Horizons Marijuana Life Sciences ETF (HMMJ) rose nearly 4.6%, while the ETFMG Alternative Harvest ETF (MJ) rose ~1.6%. Let’s look at how some of the major cannabis stocks performed last week. […]

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    APHA, CRON, and Other Cannabis Stocks Resume Their Falls

    On May 2, the overall sentiment surrounding the cannabis sector appeared to be negative.

    By Adam Jones
  • uploads///foliage _
    Company & Industry Overviews

    Comparing GW Pharmaceuticals’ Returns to Peers

    GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.

    By Mohit Oberoi, CFA
  • uploads///organigram health canada license
    Cannabis

    OrganiGram Receives Expansion License from Health Canada

    On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.

    By Rajiv Nanjapla
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Comparing Cannabis Stocks’ Valuation Multiples in November

    Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.

    By Adam Jones
  • uploads///
    Cannabis

    Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?

    On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.

    By Rajiv Nanjapla
  • uploads///Implied Demand
    Company & Industry Overviews

    Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks

    On November 7, US Attorney General Jeff Sessions resigned from his position.

    By Adam Jones
  • uploads///organigram analysts revise
    Cannabis

    OrganiGram Stock Falls after Disappointing Q3 Earnings

    Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.

    By Rajiv Nanjapla
  • uploads///aurora cannabis new cco
    Cannabis

    Aurora Cannabis Appoints New Chief Commercial Officer

    As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

    By Rajiv Nanjapla
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///hexo israel marijuana
    Cannabis

    HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%

    Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.

    By Rajiv Nanjapla
  • uploads///aphria and organigram comparing
    Cannabis

    Is Aphria or OrganiGram a Better Buy for Investors?

    Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.

    By Rajiv Nanjapla
  • uploads///OGI_
    Cannabis

    What to Expect from OrganiGram’s Q3 Earnings

    OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Aphria Stock Rose More than 8% after Stifel’s Upgrade

    Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

    Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

    By Rajiv Nanjapla
  • uploads///Acb_
    Cannabis

    Why Did Raymond James Downgrade OrganiGram?

    On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

    By Rajiv Nanjapla
  • uploads///green thumb store
    Cannabis

    Green Thumb Keeps Expanding Its Operations in Las Vegas

    On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

    By Rajiv Nanjapla
  • uploads///Canopy_Growth_
    Cannabis

    Canopy Growth Announces Initiatives to Regain Market Share

    In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Why Canadian Cannabis Sales Dipped Slightly in April

    In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

    By Rajiv Nanjapla
  • uploads///medmen relief
    Cannabis

    MedMen’s Medical Marijuana Dispensary License Revoked in Virginia

    The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’

    Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.

    By Rajiv Nanjapla
  • uploads///us marijuana legal
    Cannabis

    Canopy Growth CEO Expects US to Legalize Cannabis by 2022

    Amid the growing support for cannabis legalization, Canopy Growth (NYSE:CGC) CEO David Klein expects the federal government to legalize marijuana by 2022.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Top 2 Cannabis Stocks to Buy, Interest in the Sector Reignites

    After underperforming the broader equity markets in the first quarter, the cannabis sector has been showing a strong recovery in the second quarter.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Curaleaf Expands Select Brand Medical Products in Connecticut

    On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Canada’s Cannabis Oil Exports Rose More than 450% in 2019

    Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Acquires Another Property in Pennsylvania

    Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Illinois Reports Record Recreational Cannabis Sales in May

    Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.

    By Rajiv Nanjapla
  • uploads///Vireo Health
    Cannabis

    Vireo Health Terminates Bruce Linton as Its Executive Chairman

    On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.

    By Rajiv Nanjapla
  • uploads///cannabis stocks broader market
    Cannabis

    Why California’s Legal Cannabis Sales Could Fall This Year

    The budget proposed by Governor Gavin Newsom projected a decline in California’s cannabis sales. COVID-19 induced a recession in the US economy.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Closing Facility Could Cost Tilray $28 Million in Non-Cash Charges

    On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.

    By Rajiv Nanjapla
  • uploads///Jamaica
    Cannabis

    Why Are Canadian Cannabis Companies Leaving Jamaica?

    Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

    By Rajiv Nanjapla
  • uploads///OGI_
    Cannabis

    Why OrganiGram Stock Rose More than 11% Yesterday

    OrganiGram (NASDAQ:OGI) had good news for patients who use cannabis for medical purposes. The company expanded its medical cannabis offerings.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Curaleaf: Analysts’ Recommendations after Its Q1 Earnings

    Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

    By Rajiv Nanjapla
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis to Enter US CBD Market, Stock Rises over 30%

    On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it has signed an agreement to acquire Reliva—a US-based CBD company.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Charlotte’s Web Reports Mixed Q1 Performance

    Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

    By Rajiv Nanjapla
  • uploads///GW Pharmaceuticals results
    Cannabis

    GW Pharmaceuticals Stock Rises on Higher Epidiolex Sales

    On Monday, GW Pharmaceuticals reported its first-quarter earnings. The company beat analysts’ revenue, EBITDA, and EPS expectations.

    By Rajiv Nanjapla
  • uploads///TLRY
    Cannabis

    Tilray Posts Q1 Results, Stock Falls, and Net Losses Widen

    On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.

    By Rajiv Nanjapla
  • uploads///aphria stock fell
    Cannabis

    Why Did Aphria Stock Fall 7% on May 8?

    On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.

    By Rajiv Nanjapla
  • uploads///charlottes web upcoming earnings
    Cannabis

    Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings

    Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

    By Rajiv Nanjapla
  • uploads///tilray_
    Cannabis

    Tilray’s Q1 Earnings Could Boost Its Stock Price

    The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.